The presence of particulate matter in parenteral products is considered a major risk factor for immunogenicity, and exemplified by a sizing gap in the characterization of subvisible particles. 

In this seminar, we demonstrate how the combination of particle sizing technologies provides size, concentration and identification of particles covering nm to mm size range.